Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (2s,4s)-6-fluoro-2',5'-dioxospiro(chroman-4,4'-imidazolidine)-2-carboxamide
2. Snk 860
3. Snk-860
1. 136087-85-9
2. Aldos
3. Snk-860
4. Snk 860
5. Fidarestat [inn]
6. Chembl84446
7. (2s,4s)-2-aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione
8. 8sh8t1164u
9. (+)-(2s,4s)-6-fluoro-2',5'-dioxospiro(chroman-4,4'-imidazolidine)-2-carboxamide
10. (2s,4s)-6-fluoro-2',5'-dioxospiro[2,3-dihydrochromene-4,4'-imidazolidine]-2-carboxamide
11. Fid
12. (2s,4s)-6-fluoro-2',5'-dioxospiro[chromane-4,4'-imidazolidine]-2-carboxamide
13. Sk 860
14. Aldos (tn)
15. Fidarestat (jan/inn)
16. Unii-8sh8t1164u
17. Ncgc00167477-01
18. (s,s)-fidarestat
19. (2s,4s)-6-fluoro-2',5'-dioxospiro(3,4-dihydro-2h-1-benzopyran-4,4'-imidazolidine)-2-carboxamide
20. Fidarestat [mi]
21. Fidarestat [jan]
22. (2s,4s)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide
23. Dsstox_cid_26654
24. Dsstox_rid_81798
25. Dsstox_gsid_46654
26. Schembl48827
27. Spiro(4h-1-benzopyran-4,4'-imidazolidine)-2-carboxamide, 6-fluoro-2,3-dihydro-2',5'-dioxo-, (2s-cis)-
28. Snk860
29. Dtxsid4046654
30. Bdbm16512
31. Bcp07501
32. Zinc3789766
33. Tox21_112481
34. Akos016011245
35. Db02021
36. (2s,4s)-6-fluoro-2',5'-dioxo-2,3-dihydrospiro[chromene-4,4'-imidazolidine]-2-carboxamide
37. As-84120
38. Bs160360
39. Spiro(4h-1-benzopyran-4,4'-imidazolidine)-2-carboxamide, 2,3-dihydro-2',5'-dioxo-6-fluoro-, (2s-cis)-
40. Spiro[4h-1-benzopyran-4,4'-imidazolidine]-2-carboxamide,6-fluoro-2,3-dihydro-2',5'-dioxo-, (2s,4s)-
41. Hy-105185
42. Cas-136087-85-9
43. Cs-0025231
44. D01842
45. D86149
46. 087f859
47. J-521366
48. Q15633938
49. ((2s,4s)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide
50. (2s,4s)-6-fluoro-2'',5''-dioxo-2,3-dihydrospiro[1-benzopyran-4,4''-imidazolidine]-2-carboxamide
| Molecular Weight | 279.22 g/mol |
|---|---|
| Molecular Formula | C12H10FN3O4 |
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 1 |
| Exact Mass | 279.06553397 g/mol |
| Monoisotopic Mass | 279.06553397 g/mol |
| Topological Polar Surface Area | 111 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 485 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
84
PharmaCompass offers a list of Fidaresstat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Fidaresstat manufacturer or Fidaresstat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fidaresstat manufacturer or Fidaresstat supplier.
A Snk 860 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Snk 860, including repackagers and relabelers. The FDA regulates Snk 860 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Snk 860 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Snk 860 supplier is an individual or a company that provides Snk 860 active pharmaceutical ingredient (API) or Snk 860 finished formulations upon request. The Snk 860 suppliers may include Snk 860 API manufacturers, exporters, distributors and traders.
click here to find a list of Snk 860 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Snk 860 DMF (Drug Master File) is a document detailing the whole manufacturing process of Snk 860 active pharmaceutical ingredient (API) in detail. Different forms of Snk 860 DMFs exist exist since differing nations have different regulations, such as Snk 860 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Snk 860 DMF submitted to regulatory agencies in the US is known as a USDMF. Snk 860 USDMF includes data on Snk 860's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Snk 860 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Snk 860 suppliers with USDMF on PharmaCompass.
Snk 860 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Snk 860 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Snk 860 GMP manufacturer or Snk 860 GMP API supplier for your needs.
A Snk 860 CoA (Certificate of Analysis) is a formal document that attests to Snk 860's compliance with Snk 860 specifications and serves as a tool for batch-level quality control.
Snk 860 CoA mostly includes findings from lab analyses of a specific batch. For each Snk 860 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Snk 860 may be tested according to a variety of international standards, such as European Pharmacopoeia (Snk 860 EP), Snk 860 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Snk 860 USP).
